Not Yet Recruiting
FHND1002 for ALS Treatment: Phase 2
NCT07138014
- Conditions
- Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
- Locations
-
Not specified